Neurogene

Digitally generated DNA fragment on a dark background
Biotech

Patient put in critical condition by Neurogene gene therapy dies

Neurogene disclosed the adverse event Nov. 11 and said the patient was in critical condition Nov. 18.
Nick Paul Taylor Nov 22, 2024 3:57am
FDA stop sign

Neurogene stops Batten gene therapy after FDA denies request

Nov 19, 2024 6:30am
rare diseases

FDA picks Denali, Neurogene and more for rare disease program

Jun 4, 2024 2:51pm
snow mountain winter

BioMarin CEO replaces commercial chief—Chutes & Ladders

Jan 19, 2024 8:30am
Illustration connected puzzle pieces with the acronym MA

Neurogene inks Neoleukin reverse merger to fund gene therapies

Jul 18, 2023 8:47am
DNA helix forming inside a test tube

Neurogene adds another $115M to the pot

Dec 17, 2020 8:42am